GlassScriptPhysician profile
Sarah Suejin Kim
NPI 1609404300
$2,272.50
in general payments reported to CMS, 2019-2025
16 companies · $778 in 2025
The $778 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $281 · 2022: $241 · 2023: $727 · 2024: $245 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.19 |
| Education | $266.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $535.84 | 2023-2025 | Tremfya |
| Abbvie INC. | $507.68 | 2021-2025 | |
| Galderma Laboratories, L.P. | $401.38 | 2023-2025 | Nemluvio |
| Genzyme Corporation | $366.92 | 2021-2023 | |
| Lilly USA, LLC | $90.59 | 2022-2023 | Taltz, Olumiant |
| Tolmar, INC. | $64.42 | 2025 | Fensolvi |
| Amgen INC. | $61.35 | 2023-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $48.64 | 2022-2024 | Sotyktu |
| Pfizer INC. | $37.49 | 2022 | |
| Incyte Corporation | $29.06 | 2022 | |
| Sun Pharmaceutical Industries INC. | $28.02 | 2025 | |
| Dexcom, INC. | $24.40 | 2024 | Dexcom G6 Transmitter |
| Almirall LLC | $23.85 | 2022 | |
| Phadia US INC. | $19.60 | 2022 | |
| Biofrontera INC. | $19.53 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.